MED9 Antikörper

Produktnummer ABIN5647949

Produktdetails anti-MED9 Antikörper

Target: MED9 (Mediator Complex Subunit 9 (MED9))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MED9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Aufreinigung: Antigen affinity purified

Immunogen: A recombinant human protein corresponding to amino acids A55-E146 was used as the immunogen for the MED9 antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the MED9 antibody should be determined by the researcher.\. Western Blot: 0.5-1 μg/mL,IHC (FFPE): 1-2 μg/mL,Direct ELISA (recombinant human protein): 0.1-0.5 μg/mL (BSA-free format available)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Lagerung: -20 °C

Informationen zur Lagerung: After reconstitution, the MED9 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.

Details zu MED9

Target: MED9 (Mediator Complex Subunit 9 (MED9))

Andere Bezeichnung: MED9 / MED25 (MED9 Produkte)

Synonyme: MED25 antikoerper, BC019367 antikoerper, Med25 antikoerper, mediator complex subunit 9 antikoerper, mediator complex subunit 9 L homeolog antikoerper, MED9 antikoerper, med9.L antikoerper, Med9 antikoerper

Hintergrund: MED9 is a member of the mediator complex of proteins that promote activation of RNA polymerase II through direct interactions with transcription factors. This MED9 gene is located within the Smith-Magenis syndrome region on chromosome 17.

UniProt: Q9NWA0

Pathways: Regulation of Lipid Metabolism by PPARalpha